Intelligence Layer

News

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

Hub signal

Search-friendly coverage

Keep the current route structure, but present it with the same premium hierarchy as the homepage.

Explore

Search-friendly hub pages

Regulators

Regulatory Updates

FDA, EMA, PMDA, MHRA, and global regulatory coverage in one crawlable hub.

Trials

Clinical Trial Watch

Phase readouts, trial design updates, enrollment milestones, and study results.

Pipeline

Drug Pipeline

Regulatory pipeline signals, approvals, and market-moving development updates.

Live pharma index

Full coverage

Every signal, indexed and searchable

Browse the complete catalog across approvals, trials, research, devices, and deals - refreshed twice a day.

350+

trusted sources

8k+

indexed stories

2x

daily refresh

Coverage

Latest indexed stories

9,192 stories indexed, page 114 of 154

🇯🇵Jan 1, 1970Industrytaisho.co.jp

Featured signal

List of Business Locations｜Taisho Pharmaceutical

Publisher

Taisho Pharmaceutical

Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.

Taisho PharmaceuticalOriginal publisher link

Canonical metadata stays public, while full text remains on the original site.

🇯🇵Jan 1, 1970Devicessysmex.co.jp

ç ç©¶éçºãã¥ã¼ã¹ | ã·ã¹ã¡ãã¯ã¹ - Sysmex

Sysmex (IR News)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Medicamenti per uso umano omologati contenenti nuovi principi attivi

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Médicaments à usage humain autorisés contenant de nouveaux principes actifs

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Swissmedic eGov

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Updated specification documents

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Medical devices

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Complementary & herbal medicines

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

PDF invoice by e-mail

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Batch recalls human medicines

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Medicines > Out-of-Stock

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Authorisations of human medicinal products with a new active substance and additional indications 2025

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Tranylcypromine Rivopharm, Filmtabletten (Tranylcyprominum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Teizeild®, Konzentrat zur Herstellung einer Infusionslösung (Teplizumabum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Reblozyl®, Pulver zur Herstellung einer Injektionslösung (Luspaterceptum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Ojemda®, Pulver zur Herstellung einer Suspension zum Einnehmen (Tovorafenibum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Ogsiveo®, Filmtabletten (Nirogacestatum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Inluriyo®, Filmtabletten (Imlunestrantum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Imdylltra®, Pulver für ein Konzentrat und Stabilisatorlösung zur Herstellung einer Infusionslösung (Tarlatamabum)

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Kurzbericht Zulassung – Winrevair®

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Kurzbericht Zulassung – mRESVIA®

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Kurzbericht Zulassung – Enhertu®

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Kurzbericht Zulassung – Breyanzi®

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Über uns

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

eGov-Portal (Fachanwendungen)

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Anpassung der Swissmedic Gebührenverordnung per 1. Juli 2026

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Tagung des ICH (International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use)

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Neue Möglichkeiten zur Produktregistrierung in swissdamed: Online-Editor und Machine-to-Machine (M2M) Schnittstelle, sowie Registrierung von Master UDI-DI

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Komplementär- und Phytoarzneimittel

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

PDF Rechnung per E-Mail

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Chargenrückruf – Mycostatin, Suspension zum Einnehmen 100'000 I.E./ml

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Chargenrückruf – Fixaprost, Augentropfen Einzeldosen

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Chargenrückrufe Humanarzneimittel

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Out-of-Stock – Betaseptic, alkoholische Povidon-Iod-Lösung 1000 ml

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Arzneimittel > Out-of-Stock (Lieferengpässe)

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

DHPC – MisoOne (misoprostolum)

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

DHPC – Miostat (carbacholum)

Swissmedic - Medical Devices & SaMDOriginal source

🇨🇭Jan 1, 1970Regulatoryswissmedic.ch

Zugelassene Humanarzneimittel mit neuen Wirkstoffen

Swiss Agency for Therapeutic Products (Swissmedic)Original source

🌍Jan 1, 1970Industrysotio.com

SOTIO Receives U.S. FDA Orphan Drug Designation for SOT10...

SOTIO Biotech (PPF Group)Original source

🌍Jan 1, 1970Industrysotio.com

SOTIO Presents Positive Results from Non-Human Primate St...

SOTIO Biotech (PPF Group)Original source

🌍Jan 1, 1970Industrysotio.com

SOTIO Announces Promotion of Vivi Boura to Chief Medical ...

SOTIO Biotech (PPF Group)Original source

🇺🇸Jan 1, 1970Industrysolidbio.com

Engaging the Community - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Charity Partners - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Strength in Community - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Expanded Access Policy - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Clinical Trials - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Resources & Policies - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

What is Frataxin?

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

What is Friedreich’s Ataxia?

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

For Patients - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Why Gene Transfer?

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

What is Duchenne?

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Patient Stories - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

Duchenne Muscular Dystrophy - Solid Biosciences

Solid BiosciencesOriginal source

🇺🇸Jan 1, 1970Industrysolidbio.com

What is CPVT?

Solid BiosciencesOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Verley secures $38 million Series A to commercialize high-performance whey protein ingredients through precision fermentation — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Signadori Bio appoints Dr. Selwyn Ho, MB BS as Chief Executive Officer to lead company into next stage of growth — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

News 23 March, 2026 Sensorion reports six-month update from the Audiogene Phase 1/2 Trial of SENS-501 and advances GJB2-GT (SENS-601) toward first-in-human clinical development

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Sensorion announces leadership changes — Sofinnova Partners

Sofinnova PartnersOriginal source

🇫🇷Jan 1, 1970Investorsofinnovapartners.com

Neurent Medical Raises €62.5 million in Oversubscribed Series C Financing to Accelerate NEUROMARK® Commercial Expansion to treat Chronic Rhinitis — Sofinnova Partners

Sofinnova PartnersOriginal source